Skip to main content
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Site Search
News
Company Info
News
Events & Presentations
Events Calendar
Presentations
Stock Information
Stock Info
Financial Information
Financial Results
SEC Filings
Governance
Governance Documents
Committee Composition
Management
Board of Directors
Resources
Investor Emails Alerts
Investor Contacts
RSS Feeds
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
12/14/2021
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders
11/30/2021
AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
11/23/2021
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
11/12/2021
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
08/13/2021
AgeX Therapeutics Reports Second Quarter 2021 Financial Results
07/23/2021
AgeX Therapeutics and LyGenesis Terminate Merger Negotiations
05/17/2021
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
03/31/2021
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
03/12/2021
AgeX Announces Preprint Article Relating to Regeneration, Aging, and Cancer
03/10/2021
AgeX Therapeutics to Collaborate with The Ohio State University to Generate Proof-of-Concept Animal Data for AgeX’s Brown Adipose Tissue (BAT) Cell Therapy Candidate for Diabetes and Obesity
03/02/2021
AgeX Therapeutics and LyGenesis to Negotiate Merger Agreement